The genetic cause of CBAVD is mostly linked to a cystic fibrosis transmembrane conductance regulator (CFTR) mutation, and the symptoms account for 25% of the OA population [146]. Here, CFTR is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.